These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23073774)

  • 1. Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk.
    Magalhães JF; Cortinhas AJ; Albuquerque CM; Baptista CS; Ribeiro R; Viegas C; Matos A; Machado J; Pires MA; Guedes-Pinto H; Martins-Bessa A; Leitão JC; Bastos E
    Mol Biol Rep; 2013 Jan; 40(1):449-55. PubMed ID: 23073774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian Population.
    Dargahi Abbasabad G; Banan Khojasteh SM; Eskandari Naji H; Zamani MR; Hajipour H; Serati-Nouri H
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1717-1720. PubMed ID: 29938471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between single nucleotide polymorphisms in -174G/C and -634C/G promoter region of interleukin-6 and prostate cancer.
    Bao S; Yang W; Zhou S; Ye Z
    J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):693-6. PubMed ID: 19107369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukins-6 -174G/C (rs1800795) and -572C/G (rs1800796) polymorphisms and prostate cancer risk.
    Iqbal MS; Peng K; Sardar N; Iqbal MH; Ghani MU; Tanvir F; Gu D; Guohua Z; Duan X
    Mol Immunol; 2023 Dec; 164():88-97. PubMed ID: 37989067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 promoter variants, prostate cancer risk, and survival.
    Tindall EA; Severi G; Hoang HN; Southey MC; English DR; Hopper JL; Giles GG; Hayes VM;
    Prostate; 2012 Dec; 72(16):1701-7. PubMed ID: 22782910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
    Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
    Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10 polymorphisms and prostate cancer risk: a meta-analysis.
    Shao N; Xu B; Mi YY; Hua LX
    Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):129-35. PubMed ID: 21339768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interleukin-6 -174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis.
    Zhang H; Xu Y; Li L; Liu R; Ma B
    Urol Int; 2012; 88(4):447-53. PubMed ID: 22516897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6-174G > C (rs1800795) polymorphism distribution and its association with rheumatoid arthritis: A case-control study and meta-analysis.
    Dar SA; Haque S; Mandal RK; Singh T; Wahid M; Jawed A; Panda AK; Akhter N; Lohani M; Areeshi MY; Rai G; Datt S; Bhattacharya SN; Ramachandran VG; Das S
    Autoimmunity; 2017 May; 50(3):158-169. PubMed ID: 28010120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-6 gene polymorphisms in the development of prostate cancer.
    Chen CH; Gong M; Yi QT; Guo JH
    Genet Mol Res; 2015 Oct; 14(4):13370-4. PubMed ID: 26535651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese.
    Liu J; Song B; Bai X; Liu W; Li Z; Wang J; Zheng Y; Wang Z
    BMC Cancer; 2010 Aug; 10():456. PubMed ID: 20735825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between -174 G/C promoter polymorphism of the interleukin-6 gene and progression of prostate cancer in North Indian population.
    Kesarwani P; Ahirwar DK; Mandhani A; Mittal RD
    DNA Cell Biol; 2008 Sep; 27(9):505-10. PubMed ID: 18694328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASSOCIATIONS OF IL-6 -174G>C AND IL-10 -1082A>G POLYMORPHISMS WITH SUSCEPTIBILITY TO CELIAC DISEASE: EVIDENCE FROM A META-ANALYSIS AND LITERATURE REVIEW.
    Aflatoonian M; Sivandzadeh G; Morovati-Sharifabad M; Mirjalili SR; Akbarian-Bafghi MJ; Neamatzadeh H
    Arq Gastroenterol; 2019; 56(3):323-328. PubMed ID: 31633733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of interleukin-10 (IL-10) gene 4 polymorphisms on peripheral blood IL-10 variation and prostate cancer risk based on published studies.
    Men T; Yu C; Wang D; Liu F; Li J; Qi X; Yang C; Jiang W; Wei X; Li X; Wang B; Mi J; Tian G
    Oncotarget; 2017 Jul; 8(28):45994-46005. PubMed ID: 28526808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.
    Yin YW; Li JC; Zhang M; Wang JZ; Li BH; Liu Y; Liao SQ; Zhang MJ; Gao CY; Zhang LL
    Gene; 2013 Oct; 529(1):94-103. PubMed ID: 23954871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between IL-6 -174G>C polymorphism and lung cancer: a meta-analysis.
    Liu Y; Song XL; Zhang GL; Peng AM; Fu PF; Li P; Tan M; Li X; Li M; Wang CH
    Genet Mol Res; 2015 Jan; 14(1):163-9. PubMed ID: 25729947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of IL-6 -174 G>C Polymorphism with Susceptibility to Colorectal Cancer and Gastric Cancer: a Systematic Review and Meta-Analysis.
    Jafari-Nedooshan J; Dastgheib SA; Kargar S; Zare M; Raee-Ezzabadi A; Heiranizadeh N; Sadeghizadeh-Yazdi J; Neamatzadeh H
    Acta Medica (Hradec Kralove); 2019; 62(4):137-146. PubMed ID: 32036845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between -174G>C polymorphism in the IL-6 promoter region and the risk of obesity: A meta-analysis.
    Hu M; Yu Z; Luo D; Zhang H; Li J; Liang F; Chen R
    Medicine (Baltimore); 2018 Aug; 97(33):e11773. PubMed ID: 30113463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer.
    Zhai K; Yang Y; Gao ZG; Ding J
    Oncotarget; 2017 Jul; 8(27):44490-44497. PubMed ID: 28548958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 gene polymorphisms and CAD risk: a meta-analysis.
    Yang Y; Zhang F; Skrip L; Lei H; Wang Y; Hu D; Ding R
    Mol Biol Rep; 2013 Mar; 40(3):2589-98. PubMed ID: 23242654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.